Status:
UNKNOWN
Identification of New Inborn Errors of Immunity
Lead Sponsor:
University of Zurich
Conditions:
Primary Immune Deficiency Disorder
Eligibility:
All Genders
Brief Summary
Analysis of DNA samples of patients with molecularly undetermined PID by whole exome/genome sequencing. Transcriptome analysis of patients with molecularly undetermined PID.
Eligibility Criteria
Inclusion
- Patients with primary immunodeficiency (PID)
- Male and Female participants 0 years to adult age (any)
- Written informed consent by the participant after information about the research project
Exclusion
- Secondary immunodeficiency
- Refusal to enter the study
Key Trial Info
Start Date :
August 15 2015
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 15 2025
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT03414528
Start Date
August 15 2015
End Date
August 15 2025
Last Update
January 30 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Children's Hospital Zurich
Zurich, Switzerland, 8032